EQT, ADIA and CPP Investments to Acquire QIAGEN

Hg, ADIA and CPP Investments acquire minority stake in IFS at €15 billion valuation

April 9, 2025

Software

Hg has increased its stake in enterprise software provider IFS to become a co-control shareholder alongside EQT, as new minority investors — a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA) and the Canada Pension Plan Investment Board (CPP Investments) — buy shares from EQT, TA Associates and other minority holders. The transaction values IFS at over EUR 15 billion and supports the company’s continued AI-driven growth after surpassing €1 billion in ARR and more than 7,000 employees globally.

EQT Consortium Completes Acquisition of Nord Anglia Education

March 20, 2025

Education

A consortium led by EQT, together with Neuberger Berman Private Markets, CPP Investments, CF Alba, and Dubai Holding, completed its acquisition of Nord Anglia Education. The transaction values Nord Anglia at USD 14.5 billion and expands the company’s global shareholder base to support continued growth and innovation in premium international education.

Cinven Acquires Majority Stake in BioAgilytix; Cobepa Reinvests

December 20, 2021

Healthcare Services

International private equity firm Cinven has agreed to acquire a majority stake in BioAgilytix through a recapitalization, with current investor Cobepa remaining a significant minority investor. GHO Capital has realised its investment and will exit; the transaction will provide funding to support BioAgilytix’s international expansion, capacity and capability investments, and buy-and-build strategy in large-molecule bioanalytical services. BioAgilytix is headquartered in Durham, North Carolina and employs about 870 staff across the United States, Europe and Australia.

EQT Acquires LSP (Life Sciences Partners)

November 10, 2021

Financial Services

EQT AB has acquired LSP (Life Sciences Partners), a leading European life-sciences venture capital firm, in a transaction that creates a new EQT Life Sciences business line. The deal values the upfront consideration at EUR 450 million (25% cash / 75% EQT shares) with a EUR 25 million earn‑out paid on meeting fundraising targets (total consideration EUR 475 million at close); LSP's 34-person team and partners join EQT to strengthen its healthcare investing capabilities.

EQT Public Value Invests in BioGaia AB

November 2, 2020

Biotechnology

EQT Public Value, an EQT Partners fund, has committed to acquire 1,625,000 B shares in Swedish probiotic company BioGaia AB via a directed share issue for SEK 650 million, subject to approval at an extraordinary general meeting. The investment is a minority growth-capital commitment intended to support BioGaia's continued global expansion by providing access to EQT's healthcare expertise, advisory network and in-house digital and sustainability teams.

EQT Acquires Igenomix from Charme Capital; Management and Charme Reinvest

June 18, 2019

Biotechnology

EQT VIII (EQT Partners) has agreed to acquire a majority stake in Igenomix, a Valencia-headquartered leader in reproductive genetic services, from Charme Capital, management and other minority owners. Charme Capital and the Igenomix management team will reinvest significant minority stakes, and EQT will support the company's continued international expansion and R&D-led growth.